WEBULL
WebtradeDownload

Insperity (NSP) Sees Margin Recovery Take Shape After Q3 Turnaround Raises Valuation Questions

Simply Wall St · 1d ago

Insperity (NSP) lit up investor screens after its third quarter report showed a return to adjusted profitability, sharp EBITDA growth, and a clearer margin recovery path supported by pricing and client mix shifts.

Recent trading has been choppy for Insperity, with a 1-day share price return of 5.16% after the Q3 release, following a 7-day share price return that was down 9.75%. The year-to-date share price return is up 26.05% and the 1-year total shareholder return is 16.33%, set against a much weaker 3- and 5-year total shareholder return where investors have seen declines of 48.01% and 51.77%. This suggests that enthusiasm around the margin recovery story is improving but still rebuilding from a long period of underperformance.

Scan beyond Insperity and compare this margin recovery story with other companies on our curated list of 36 high quality undervalued stocks that combine earnings power with balance sheet strength.

Insperity has already rewarded investors who stayed through the slump, yet the share price still trails its longer term losses. Is the recent rebound the main act, or just the opening move as valuation resets?

Most Popular Narrative: 6% Undervalued

On the most followed view, Insperity’s fair value sits at $51.75, slightly above the last close of $48.68. This puts the recent rally in context as a partial catch up rather than a full rerating.

The rollout of Insperity HRScale with Workday to mid-sized clients between 150 and 5,000 employees, now with about 8,000 worksite employees sold and a shift of spending from development to revenue-producing operations, points to a new revenue stream that management expects to carry profitability at or above HR360 levels and support earnings growth.

See why 6 investors see Insperity as 6% undervalued.

Result: Fair Value of $51.75 (UNDERVALUED)

Still, the Insperity narrative can break if healthcare costs flare faster than repricing efforts or if HRScale adoption stalls and leaves margins under renewed pressure.

Find out about the key risks to this Insperity narrative.

Next Steps

Mixed signals around Insperity’s recovery story can spark either optimism or caution, so move quickly and review both sides of the ledger with the 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Insperity?

Insperity offers one angle on earnings quality and recovery, yet your portfolio stays more resilient when you line up a few different plays from other corners of the market.

Use the Simply Wall St Screener to pressure test your next moves and avoid leaving potential opportunities on the table.